Japan, Aug. 24 -- MAVERIX ONCOLOGY INC has got intellectual property rights for 'SMALL MOLECULE-DRUG CONJUGATES OF GEMCITABINE MONOPHOSPHATE.' Other related details are as follows:

Application Number: JP,2024-007282

Category (FI): C07H19/10,A61K31/7068,A61P35/00,G01N33/573@A,G01N33/48@M

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Jan. 22, 2024

Publication Date: April 17, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....